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ABSTRACT: Human exposure to persistent organic pollutants (POPs) is a certainty, even to long banned 
pesticides like o,p0-dichlorodiphenyltrichloroethane (o,p0-DDT), and its metabolites p,p0-dichlorodiphenyl-
dichloroethylene (p,p0-DDE), and p,p0-dichlorodiphenyldichloroethane (p,p0-DDD). POPs are known to be 
particularly toxic and have been associated with endocrine-disrupting effects in several mammals, includ-
ing humans even at very low doses. As environmental estrogens, they could play a critical role in carcino-
genesis, such as in breast cancer. With the purpose of evaluating their effect on breast cancer biology, 
o,p0-DDT, p,p0-DDE, and p,p0-DDD (50–1000 nM) were tested on two human breast adenocarcinoma cell 
lines: MCF-7 expressing estrogen receptor (ER) a and MDA-MB-231 negative for ERa, regarding cell pro-
liferation and viability in addition to their invasive potential. Cell proliferation and viability were not equally 
affected by these compounds. In MCF-7 cells, the compounds were able to decrease cell proliferation and 
viability. On the other hand, no evident response was observed in treated MDA-MB-231 cells. Concerning 
the invasive potential, the less invasive cell line, MCF-7, had its invasion potential significantly induced, 
while the more invasive cell line MDA-MB-231, had its invasion potential dramatically reduced in the pres-
ence of the tested compounds. Altogether, the results showed that these compounds were able to modu-
late several cancer-related processes, namely in breast cancer cell lines, and underline the relevance of 
POP exposure to the risk of cancer development and progression, unraveling distinct pathways of action 
of these compounds on tumor cell biology. CV 2013 Wiley Periodicals, Inc. Environ Toxicol 30: 168–176, 2015. 
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INTRODUCTION
A large variety of synthetic organic chemicals of different
chemical classes have been released into the environment
over the last few decades, and human exposure to these
chemicals is a certainty, even to long banned organochlorine
pesticides like dichlorodiphenyltrichloroethane (DDT), and
its metabolites dichlorodiphenyldichloroethylene (DDE) and
dichlorodiphenyldichloroethane (DDD) (Ozonoff et al.,
1994; Li et al., 2006; Porta, 2006). These man-made chemi-
cals are environmentally persistent due to an intrinsic resist-
ance to natural degradation processes and are lipophilic,
bioaccumulate in the food chain, and may be found in
human adipose tissue, blood, and breast milk (Li et al.,
2006; Shakeel et al., 2010). For example, the half-life of
DDE in the soil may be more than 20 years (Xu et al., 2010).
In this regard, these compounds are termed persistent
organic pollutants (POPs).
POPs remain one of the most important groups of pollu-
tants to which humans are exposed to, primarily via dietary
intake of dairy products, meat, and fish (Toppari et al., 1996;
Li et al., 2006; Lee et al., 2007). It has been demonstrated
that the entire population of the world presents detectable
residues of more than one POP on their biological tissues
(Snedeker, 2001; Zumbado et al., 2005; Valeron et al.,
2009). Because of their persistence and toxicity, they are
listed in the Stockholm Convention on Persistent Organic
Pollutants, an international treaty designed to limit and ulti-
mately eliminate their production, use, storage, and release.
In recent years, attention has been focused on the poten-
tial of some chemicals to act as endocrine disruptors, even at
very low doses, being proposed for a number of adverse
human health effects, including infertility, abnormal prenatal
and childhood development, and cancers (Ozonoff et al.,
1994; Lai et al., 2001). Evidence from experimental assays
suggests that a number of POPs interfere with the function
of the endocrine system by mimicking a hormone, blocking
the effects of normal endogenous hormones, or by altering
or modifying the synthesis, metabolism, or transport of hor-
mones (Soto et al., 1995; Casals-Casas et al., 2008; Hanet
et al., 2008; Swedenborg et al., 2009; Casals-Casas and
Desvergne, 2011). Specifically, o,p0-DDT, the best known
and most extensively studied xenoestrogen, acts through the
classic estrogen receptor (ER) pathways (Mason and
Schulte, 1981; Robison et al., 1985a; Steinmetz et al., 1996).
In 1993, Wolff et al. (1993) first reported the presumed
positive association between p,p0-DDE—the main metabo-
lite of DDT—and breast cancer. Breast cancer is one of the
most commonly diagnosed cancers and the second leading
cause of cancer deaths in women worldwide today (Wolff
and Weston, 1997; Lacey et al., 2002). Several studies have
established that estrogens are predominantly involved in
the initiation and proliferation of breast cancer. On the
other hand, the progression of a tumor from being in situ
to invasive is a major prerequisite for cancer metastasis
(Stetler-Stevenson et al., 1993; Chaffer and Weinberg,
2011). This well-known association between breast cancer
and prolonged exposure to estrogens suggests that environ-
mental estrogens, such as DDT, could play a critical role in
the cellular and molecular changes that occur during breast
carcinogenesis (Gellert et al., 1972; Aronson et al., 2000;
Snedeker, 2001; Calle et al., 2002; Lopez-Cervantes et al.,
2004; Valeron et al., 2009). Furthermore, because these
chemicals are highly liposoluble and stored in the adipose
tissue, there is also a suspected association between the inci-
dence of breast cancer in women and levels of o,p0-DDT in
breast adipose tissue (Falck et al., 1992). However, epide-
miologic evidence has provided provocative but limited and
inconsistent results, despite the knowledge that they promote
tumorigenesis in rodents, as reported by the World Health
Organization (Scribner and Mottet, 1981; Robison et al.,
1985b; Lopez-Cervantes et al., 2004). These compounds are
known to bind to the ER, induce tumor-cell proliferation and
promote mammary tumor formation in rodents (Scribner and
Mottet, 1981; Robison et al., 1985b; Korach et al., 1988).
Some are considered carcinogenic, while others, like DDT,
are tumor promoters (George and Shukla, 2011).
Taking into account the confirmed presence of POPs in
human samples and their recognized endocrine disruption
ability, this work aimed to evaluate the effect of DDT and its
metabolites on several properties related to cancer, in partic-
ular breast cancer. For this purpose, o,p0-DDT, p,p0-DDE,
and p,p0-DDD were tested on two human breast adenocarci-
noma cell lines (MCF-7 and MDA-MB-231) and their
effects on proliferation, viability, and invasion potential
were evaluated. The major differences between these cell
lines are the presence of the ER and their invasive and meta-
static potential: MDA-MB-231 is a hormone-independent
cell line (ERa(-)) and have higher invasive and metastatic
potential than MCF-7, a hormone-dependent cell line
(ERa(1)) (Brooks et al., 1973; Cailleau et al., 1978; Aube
et al., 2011).
MATERIALS AND METHODS
Cells and Culture Conditions
MCF-7 cells were grown in Minimum Essential Medium
(Sigma, St. Louis, MO), supplemented with 10% fetal
bovine serum (FBS), 100 units mL21 penicillin, 100 mg
mL21 streptomycin, and 0.25 mg mL21 amphotericin B
(all from Sigma). MDA-MB 231 cells were grown in RPMI
1640 (Invitrogen, Carlsbad, CA) supplemented with 2 mM
glutamine, 15% fetal bovine serum, 100 units mL21 penicil-
lin, 100 mg mL21 streptomycin, and 0.25 mg mL21 ampho-
tericin B (all from Sigma). Both the cell lines were
maintained in a humidified atmosphere of 5% CO2–95%
air. Culture medium was changed every 2–3 days, and the
culture was split every 7 days, corresponding to 90–95%
of confluence with the used cell culture conditions. For
Effect on Cell Invasion Potential
The effect of the compounds (o,p0-DDT and p,p0-DDD—50,
100, and 1000 nM; p,p0-DDE—50, 100, and 250 nM) on cell
invasive potential was tested using Millipore QCM 24-well
assay kit (Merck Millipore, Madrid, Spain), according to the
manufacturer’s instructions. Cells (7 3 105 cells/mL) were
transferred to rehydrated kit inserts and treated with the com-
pounds. Control inserts (without compounds) were also
used. After incubation for 24 h at 37C, invading cells were
detached, lysed, and subsequently detected by CyQuant
GR
VR
dye. Detection was carried out at 480/520 nm using a
Perkin-Elmer LS 45 fluorometer.
Statistical Analysis
Values are expressed as the arithmetic mean 6 standard
error of the mean (SEM) of control treatment (0.1% DMSO)
percentage. All the assays were performed in triplicate at
least three different times. The statistical significance of the
differences between groups was determined via one-way
analysis of variance (ANOVA), followed by Bonferroni’s
multiple comparison test. The differences were considered
statistically significant when P < 0.05.
RESULTS
With the purpose of evaluating their effect on breast
cancer biology, o,p0-DDT and its metabolites p,p0-DDE and
p,p0-DDD were tested on two human breast adenocarcinoma
cell lines: MCF-7 and MDA-MB-231. The treatments were
performed using a range of concentration between 50 nM
and 1 mM, as these compounds are known to be toxic and
with endocrine-disrupting effects, even at very low doses.
The structure of these compounds is illustrated in Figure 1.
Proliferation
The results obtained in the methyl-[3H]-thymidine incorpo-
ration assay demonstrated that cell proliferation was not
equally affected by the three compounds in the two cell
lines (Fig. 2). In MCF-7, a significant decrease in cell prolif-
eration was observed in the presence of o,p0-DDT (100–500
nM), when comparing with the control cells (35 193 6
2899 cpm). In the presence of DDT metabolites, p,p0-DDD
and p,p0-DDE, proliferation was not significantly affected
by any of the tested concentrations (50–1000 nM), except
for a significant reduction in 50 nM p,p0-DDD-treated
MCF-7 cells. Additionally, the concentration response pat-
tern differed between compounds, namely, when comparing
the o,p0-DDT “U” shaped response with the concentration-
dependent increase tendency observed in the p,p0-DDD
treatment, where the smallest concentration had a significant
reduction in proliferation. As for p,p0-DDE, no effects were
observed.
subculturing, the cells were removed enzymatically (0.25%
trypsin-EDTA, 5 min, 37C), split 1:4, and subcultured in
plastic culture dishes (21 cm2;  60 mm; Orange Scientific, 
Belgium).
Cell Proliferation Determined by Methyl-[3H]-
thymidine Incorporation into DNA
MCF-7 and MDA-MB-231 cells were seeded into 24-well 
(1.65 cm2;  14.5 mm; Orange Scientific, Belgium) plastic 
cell culture clusters in a final volume of 0.5 mL culture 
medium containing 10% and 15% FBS respectively. 
After 24 h in culture, cells were incubated with different 
concentrations (50–1000 nM) of o,p0-DDT, p,p0-DDE and 
p,p0-DDD (Sigma-Aldrich, Madrid, Spain) in culture 
medium. A control treatment was made with 0.1% of 
dimethyl sulfoxide (DMSO), the vehicle of the tested com-
pounds. After 24 h, the treatment medium was removed and 
the cells were incubated with 0.2 mL of methyl-[3H]-thymi-
dine (0.5 mCi/well; Amersham; Arlington Heights, IL) for 
4 h. The medium was removed and the cells were fixed 
by incubation in 10% trichloroacetic acid (TCA, Merck, 
Darmstadt, Germany) for 1 h at 4C. The cells were then 
washed twice with 10% TCA to remove unbound radioactiv-
ity. The plates were air-dried and the cells were lysed with 
1 M NaOH (0.28 mL/well). A 0.25-mL aliquot of the lysate 
was neutralized with HCl and mixed with scintillation fluid. 
The radioactivity of the samples was quantified by a liquid 
scintillation counter. The counts (counts per min, cpm) of 
each treatment were averaged and expressed as percentage 
of controls (0.1% DMSO) and proliferation was evaluated 
using a method of relative quantification (adapted from 
Miranda et al., 1999).
Cellular Viability Determined by
the LDH Assay
For the viability experiments, MCF-7 and MDA-MB-231 
cells were seeded into 24-well (1.65 cm2;  14.5 mm; 
Orange Scientific, Belgium) plastic cell culture clusters in a 
final volume of 0.5 mL culture medium containing 10%
and 15% FBS, respectively. Cells were treated for 24 h, 
following the same treatment protocol as in proliferation 
evaluation, and cell viability was assessed by the lactate 
dehydrogenase (LDH) assay as described in the literature 
(Bergmeyer and Bernt, 1974). Briefly, culture medium was 
removed and cells were preincubated with the compounds in 
culture medium, at 37C for 24 h. After treatment, cellular 
leakage of the cytosolic enzyme LDH into the extracellular 
(culture) medium was measured spectrophotometrically, by 
quantification of the decrease in absorbance of NADH 
during the reduction in pyruvate to lactate, and normalized 
to the intracellular LDH activity, measured after recovery 
of adherent cells by lysis with 0.1% Triton-X-100 in 5 mM 
Tris-HCl. Results were expressed in percentage of control.
On the other hand, MDA-MB-231 response to the treat-
ments was quite different and less marked than with MCF-7.
Comparing with the control cells (63 1226 2330 cpm), pro-
liferation was not significantly modified by the treatments
(50–1000 nM), except for a significant reduction in prolifera-
tion with 250 nM of p,p0-DDD. Furthermore, no visible con-
centration response pattern was observed.
Viability
The effect on cell viability was evaluated through the LDH
assay after 24 h of cell incubation with the compounds. As
in cell proliferation, viability was not equally affected by
these compounds (Fig. 3), either comparing between meta-
bolites or cell types.
Regarding MCF-7 cells, the “U”-shaped concentration-
response pattern observed in o,p0-DDT was maintained,
comparing with the control viability (6.04 6 0.86 Int/Ext
LDH ratio). Thus, 100 and 250 nM, but not 500 nM of
o,p0-DDT showed cytotoxicity. Regarding p,p0-DDD, the
effect was less pronounced than with DDT, but the 50 and
500 nM of the compound also negatively affected cell viabi-
lity, and this was not accompanied by a concentration-
dependent increase tendency observed in the proliferation
assay. Additionally, unlike upon proliferation, the two higher
concentrations of p,p0-DDE (500 nM and 1 mM) negatively
affected cell viability, imposing a reduction in approxi-
mately 50%. Once more, MDA-MB-231 response to the
treatments was quite different as no effect was observed on
cell viability.
Invasion Potential
Matrigel
VR
inserts were used to evaluate invasion potential in
the presence of the tested compounds. The choice of concen-
trations to be tested on either cell types was based upon
the absence of a cytotoxic effect and the requirement to test
the wider range of possible concentrations (Fig. 4). Thus, 50,
100, and 1000 nM were the tested concentrations for
o,p0-DDT and p,p0-DDD, whereas for p,p0-DDE the highest
concentration used was 250 nM.
The less invasive and metastatic cell line MCF-7 had
its invasion potential significantly induced by almost all
tested concentrations, in most cases increasing the potential
in the order of 150% in relation to control cell potential
(4.50 6 1.06 Abs 480/520 nm). No significant increase
effect was observed when 100 nM of o,p0-DDT and 50 nM
of p,p0-DDD were tested. As for p,p0-DDE, it significantly
increased the invasion potential in the smaller tested concen-
trations (50 and 100 nM), despite appearing to have less
effects in the previous evaluated parameters. Curiously, the
constitutively more invasive and, at the same time,
hormone-independent cell line MDA-MB-231 had its inva-
sion potential dramatically reduced to approximately 50%
after most of the treatments, when compared with control
(36.00 6 4.04 Abs 480/520 nm). Only the higher concentra-
tion of p,p0-DDE (250 nM) had no effect, as also observed in
the MCF-7 cell line.
DISCUSSION
Molecular data showed that compounds like POPs, a group
of environmental pollutants with endocrine disrupting pro-
perties, may act as tumor promoters through hormone-
mediated effects and can be associated with an increased
risk for hormone-related cancers including breast and pros-
tate cancers. Several POPs and some of their metabolites
have been associated with estrogen-like effects in humans,
even at very low doses (Gellert et al., 1972; Aronson et al.,
2000; Snedeker, 2001; Calle et al., 2002; Lopez-Cervantes
et al., 2004; Li et al., 2006; Valeron et al., 2009). The dis-
covery that low concentrations of these compounds,
detected in different human samples, may act on multiple
biological mechanisms is leading to a reassessment of
POPs’ impact on human beings. However, human epidemi-
ological studies on this subject have not been consistent nor
conclusive (Snedeker, 2001; Lopez-Cervantes et al., 2004;
Xu et al., 2010).
Taking into account (i) the confirmed presence of POPs
in human samples in several studies, including in our recent
project with Portuguese obese patients (Pestana et al., 2012),
(ii) their possible distribution in the organism, (iii) and their
previously described endocrine disruption ability, an evalua-
tion of the effects on tumor cell biology, is crucial. In this
regard, DDT and its metabolites (p,p0-DDE and p,p0-DDD)
were chosen to be the focus of our investigation. Indeed,
although DDT was banned in most of the world in the 1970s
Fig. 1. Molecular structures of the tested organochlorine pesticides in MCF-7 and MDA-MB-231 cells: (A) o, p0-DDT,
(B) p, p0-DDE, and (C) p, p0-DDD.
Compounds were tested in two human breast adenocarci-
noma cell lines: MDA-MB-231 and MCF-7. The major
differences between these cell lines are the presence of the
ERs and their invasive and metastatic potential (Aube et al.,
Fig. 3. Effects of (A) o, p0-DDT, (B) p, p0-DDE, and
(C) p, p0-DDD on cell viability of two breast cancer cell
lines: MCF-7 (estrogen receptor a positive) and MDA-MB-
231 (estrogen receptor a negative). Cells were treated with
the compounds, or vehicle, for 24 h and cellular viability was
evaluated by the lactate dehydrogenase (LDH) method.
Values are represented as mean of the percentage of control
group 6 SEM (n  6). The absolute control values (Int/Ext
LDH ratio) were 6.04 6 0.86 and 6.43 6 0.30 for MCF-7
and MDA-MB-231 cells, respectively. Statistical analysis
with one-way ANOVA, followed by Bonferroni’s multiple
comparison test: *significantly different from control
(vehicle), P < 0.05.
Fig. 2. Effects of (A) o, p0-DDT, (B) p, p0-DDE, and 
(C) p, p0-DDD on cell proliferation of two breast cancer cell 
lines: MCF-7 (estrogen receptor a positive) and MDA-MB-
231 (estrogen receptor a negative). Cells were treated with 
the compounds, or vehicle, for 24 h. Cellular growth was 
measured by methyl-[3H]-thymidine incorporation into DNA. 
Values are represented as mean of the percentage of control 
group 6 SEM (n  6). The absolute control values (cpm) 
were 35193 6 2899 and 63122 6 2330 for MCF-7 and 
MDA-MB-231 cells, respectively. Statistical analysis with 
one-way ANOVA, followed by Bonferroni’s multiple 
comparison test: *significantly different from control 
(vehicle), P < 0.05.
and 1980s, either the parent compound or the metabolites 
continue to be detected in a considerable amount of human 
samples. In our human study, results showed a relevant pres-
ence of DDT and its metabolites (Pestana et al., 2012). Fur-
thermore, the compounds have been attributed carcinogenic 
effects, such as in breast cancer (Dich et al., 1997; Snedeker, 
2001; Ociepa-Zawal et al., 2010; Shakeel et al., 2010).
2011). MCF-7 is associated with a hormone-dependent stage
of breast cancer and is a highly differentiated human breast
adenocarcinoma cell line, strongly responsive to estradiol,
insulin, and insulin-like growth factors (Brooks et al., 1973).
In its turn, MDA-MB-231 is a hormone-independent cell
line (ERa(2)), more invasive and metastatic than MCF-7
and is often used as a model of late-stage, hormone-inde-
pendent tumors (Cailleau et al., 1978). As stated above, the
use of these two cell lines gains relevance through the
knowledge that estrogens are involved in carcinogenesis in
the breast, predominantly in its initiation and progression
(Stetler-Stevenson et al., 1993; Chaffer and Weinberg, 2011)
and that DDT, DDD, and DDE possess the ability to inter-
fere with the signalling of these hormones (Mason and
Schulte, 1981; Robison et al., 1985a; Soto et al., 1995; Hanet
et al., 2008).
Proliferation, viability, and invasive potential were
assessed in the presence (50–1000 nM) or absence of the
tested compounds. These low concentrations, detected in dif-
ferent human samples, may act on molecular mechanisms
involved in carcinogenesis (Wolff et al., 1993; Demers et al.,
2000; Cruz et al., 2003; Lopez-Cervantes et al., 2004;
Zumbado et al., 2005; Silva et al., 2010; Xu et al., 2010;
Pestana et al., 2012). Proliferation was evaluated by methyl-
[3H]-thymidine incorporation into DNA and viability
through the LDH assay. Invasion potential was assessed
using a commercial fluorometric cell invasion assay. Cell
proliferation and viability were not equally affected by these
compounds, an expected distinct response, as both the cells
have differences in estrogen sensitivity and the tested com-
pounds have distinct potencies and mechanisms of action.
Regarding MCF-7, the hormone-dependent cell model,
the concentration response pattern upon cell proliferation
differed between compounds, namely when comparing the
inhibitory effect of middle o,p0-DDT concentrations (“U”-
shaped response: 100–500 nM) with the marked inhibition
of the lower p,p0-DDD concentration (50 nM) along with a
concentration-dependent tendency to increase in higher
concentrations. In the presence of the major and most
persistent DDT metabolite, p,p0-DDE, proliferation was not
significantly affected by none of the tested concentrations
(50–1000 nM). These results seem contradictory with
available data, where proliferation of MCF-7 cells appear
increased in the presence of DDE (Aube et al., 2008, 2011;
Bratton et al., 2012), but the main difference between those
and our own results is the much lower concentration used in
our study. Additionally, the concentration-response patterns
were essentially maintained in the viability assay although
with a more pronounced cytotoxicity found with o,p0-DDT
(100 and 250 nM). This allows us to propose that the
observed reduction in proliferation for some of the concen-
trations may be due to this reduction in viability. Further-
more, as opposed to proliferation, the two higher p,p0-DDE
concentrations (500 and 1000 nM) also negatively affected
cell viability, with a reduction in approximately 50%.
Fig. 4. Effects of (A) o, p0-DDT, (B) p, p0-DDE, and
(C) p, p0-DDD on cell invasion potential of two breast
cancer cell lines: MCF-7 (estrogen receptor a positive) and
MDA-MB-231 (estrogen receptor a negative). Cellular
invasion capacity was evaluated in cells treated with the
compounds, or vehicle, for 24 h. Values are represented as
mean of the percentage of control group 6 SEM from two
independent experiments. The absolute control values
(Abs 480/520 nm) were 4.50 6 1.06 and 36.00 6 4.04 for
MCF-7 and MDA-MB-231 cells, respectively. Statistical
analysis with one-way ANOVA, followed by Bonferroni’s
multiple comparison test: *significantly different from control
(vehicle), P < 0.05.
in women and their levels in breast adipose tissue (Falck
et al., 1992). In this sense, the increase in MCF-7 invasion
potential induced by the pesticides is of extremely relevance,
possibly promoting a more aggressive phenotype in a for-
merly less invasive cell line.
As the MDA-MB-231 cells represent a more invasive and
metastatic model of late-stage carcinoma (Cailleau et al.,
1978), one can conceive their interaction with these com-
pounds in a more systemic context, and modulating their
ability to metastasize. Considering that the tested concentra-
tions did not have effects on proliferation or viability, one
can speculate that the marked decrease in invasion can repre-
sent a change of cell differentiation stage and/or contribute
to the establishment of a new metastasis, a challenging, and
still poorly understood step when cells are in the mesenchy-
mal phenotype (Chaffer and Weinberg, 2011; Kong et al.,
2011). If on the one hand we can hypothesize that the
observed MCF-7 effects could be related with the DDT and
the estrogenic properties of its metabolites, the invasion
potential impairment of MDA-MB-231 cells can be related
with other mechanisms, for example epigenetic regulation of
phenotype and EMT. Indeed, it has been advanced that
epigenetic modulatory properties of the tested compounds
can interfere with this tightly epigenetic regulated process
(Rakitsky et al., 2000; Chaffer and Weinberg, 2011; Kong
et al., 2011).
Altogether, our results showed that these compounds
were able to modulate several properties related to carcino-
genesis, in particular in the breast. The cell type-specific
responses to nanomolar range concentrations of DDT and its
metabolites that mimic those present in biological tissues are
very promising, mainly because of the particular characteris-
tics of each cell type.
While MCF-7 had all the tested properties modulated,
namely, its invasion potential significantly increased, the
more invasive and hormone-independent cell line MDA-MB-
231 had its invasion potential dramatically reduced. Given
their particular characteristics, these results seem to indicate
distinct ways of action of these compounds in tumor cell biol-
ogy modulation and raise different challenges. Considering
their known effects, namely their estrogenic activity, further
research is needed to clarify the signalling pathways involved
in the effects demonstrated, to understand the specific risks
of exposure to these POPs and adopt therapeutic and/or pub-
lic health measures to prevent the potential health hazards
that may arise from their presence human tissues.
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